Home/ Stocks/ GUTS

Fractyl Health, Inc. Common Stock

GUTS XNAS

$0.70 +0.02 (+2.71%) ▲ 15-min delayed

Open

$0.70

High

$0.72

Low

$0.69

Volume

1.06M

Market Cap

$108.99M

About Fractyl Health, Inc. Common Stock

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 73 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$9.22M	$0.06
FY 2025	$0	$-140,954,000	$-1.86
Q3 2025	$0	$-45,603,000	$-0.71
Q2 2025	$0	$-27,889,000	$-0.57

Related Market News

No specific coverage for GUTS yet. Check out our latest market news or earnings calendar.

Get GUTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Fractyl Health, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.